Successful treatment of peritoneal recurrence after gastric cancer surgery with intravenous and intraperitoneal paclitaxel combined with S-1 chemotherapy: a case report

被引:1
作者
Miyatani, Kozo [1 ]
Miyauchi, Wataru [1 ]
Kono, Yusuke [1 ]
Shishido, Yuji [1 ]
Watanabe, Joji [1 ]
Hanaki, Takehiko [1 ]
Kihara, Kyoichi [1 ]
Matsunaga, Tomoyuki [1 ]
Yamamoto, Manabu [1 ]
Fukumoto, Yoji [1 ]
Tokuyasu, Naruo [1 ]
Takano, Shuichi [1 ]
Sakamoto, Teruhisa [1 ]
Honjo, Soichiro [1 ]
Hasegawa, Toshimichi [1 ]
Fujiwara, Yoshiyuki [1 ]
机构
[1] Tottori Univ, Sch Med, Dept Surg, Div Gastrointestinal & Pediat Surg,Fac Med, 36-1 Nishi Cho, Yonago, Tottori 6838504, Japan
关键词
Gastric cancer; Peritoneal metastasis; Peritoneal recurrence; Metachronous peritoneal metastasis; Intraperitoneal chemotherapy; Paclitaxel; S-1; DOUBLE-BLIND; GASTRECTOMY; METASTASES;
D O I
10.1186/s40792-020-00849-2
中图分类号
R61 [外科手术学];
学科分类号
摘要
Background Despite recent advances in systemic chemotherapy, the prognosis of patients with peritoneal metastases from gastric cancer still remains poor. Nonetheless, several efficacious intraperitoneal chemotherapy regimens have recently been developed for patients with peritoneal metastases. However, no study has investigated the effectiveness of intraperitoneal chemotherapy for metachronous peritoneal metastases from gastric cancer after curative surgery. Case presentation We herein report a case of a 65-year-old man who had metachronous peritoneal metastases from gastric cancer after curative total gastrectomy who had been successfully treated with intraperitoneal chemotherapy. One month after surgery, adjuvant chemotherapy with S-1 was initiated given a final pathological stage of IIIB (pT4aN2M0). However, during adjuvant chemotherapy 12 months after surgery, tumor marker levels, which had been within normal range before surgery, increased with abdominal contrast-enhanced computed tomography (CT) revealing pelvic ascites. Thereafter, staging laparoscopy was performed, and the patient was diagnosed with peritoneal recurrence of gastric cancer. Following staging laparoscopy, an intraperitoneal access port was subcutaneously implanted for subsequent intraperitoneal chemotherapy. Combined chemotherapy with intraperitoneal and intravenous administration of paclitaxel and oral S-1 was then provided. After one course of combined chemotherapy, peritoneal lavage cytology was negative for malignancy. CT showed gradually decreasing ascites, whereas tumor marker levels returned to normal. The patient continued chemotherapy without major side effects and remained progression-free for 33 months with 36 chemotherapy cycles. Conclusions A combination regimen including intraperitoneal chemotherapy could be a promising option for patients with peritoneal recurrence after gastric cancer surgery.
引用
收藏
页数:5
相关论文
共 50 条
[11]   Efficacy of conversion surgery after a single intraperitoneal administration of paclitaxel and systemic chemotherapy for gastric cancer with peritoneal metastasis [J].
Masayuki Shinkai ;
Motohiro Imano ;
Yoko Hiraki ;
Kota Momose ;
Hiroaki Kato ;
Osamu Shiraishi ;
Atsushi Yasuda ;
Masanobu Tsubaki ;
Shozo Nishida ;
Takushi Yasuda .
Langenbeck's Archives of Surgery, 2022, 407 :975-983
[12]   Weekly Intravenous and Intraperitoneal Paclitaxel Combined with S-1 for Malignant Ascites due to Advanced Gastric Cancer [J].
Kitayama, Joji ;
Ishigami, Hironori ;
Kaisaki, Shoichi ;
Hidemura, Akio ;
Kato, Masahiro ;
Otani, Kensuke ;
Kamei, Takao ;
Soma, Daisuke ;
Miyato, Hideyo ;
Yamashita, Hiroharu ;
Nagawa, Hirokazu .
ONCOLOGY, 2010, 78 (01) :40-46
[13]   Intravenous and intraperitoneal paclitaxel with S-1 for treatment of refractory pancreatic cancer with malignant ascites [J].
Takahara, Naminatsu ;
Isayama, Hiroyuki ;
Nakai, Yousuke ;
Ishigami, Hironori ;
Satoi, Sohei ;
Mizuno, Suguru ;
Kogure, Hirofumi ;
Matsubara, Saburo ;
Yamamoto, Natsuyo ;
Yamaguchi, Hironori ;
Tada, Minoru ;
Kitayama, Joji ;
Watanabe, Toshiaki ;
Koike, Kazuhiko .
INVESTIGATIONAL NEW DRUGS, 2016, 34 (05) :636-642
[14]   Intravenous and intraperitoneal paclitaxel with S-1 for treatment of refractory pancreatic cancer with malignant ascites [J].
Naminatsu Takahara ;
Hiroyuki Isayama ;
Yousuke Nakai ;
Hironori Ishigami ;
Sohei Satoi ;
Suguru Mizuno ;
Hirofumi Kogure ;
Saburo Matsubara ;
Natsuyo Yamamoto ;
Hironori Yamaguchi ;
Minoru Tada ;
Joji Kitayama ;
Toshiaki Watanabe ;
Kazuhiko Koike .
Investigational New Drugs, 2016, 34 :636-642
[15]   Oxaliplatin plus S-1 with intraperitoneal paclitaxel for the treatment of Chinese advanced gastric cancer with peritoneal metastases [J].
Shi, Min ;
Yang, Zhongyin ;
Lu, Sheng ;
Liu, Wentao ;
Ni, Zhentian ;
Yao, Xuexin ;
Hua, Zichen ;
Feng, Runhua ;
Zheng, Yanan ;
Wang, Zhenqiang ;
Sah, Birendra Kumar ;
Chen, Mingmin ;
Zhu, Zhenglun ;
He, Changyu ;
Li, Chen ;
Zhang, Jun ;
Yan, Chao ;
Yan, Min ;
Zhu, Zhenggang .
BMC CANCER, 2021, 21 (01)
[16]   Oxaliplatin plus S-1 with intraperitoneal paclitaxel for the treatment of Chinese advanced gastric cancer with peritoneal metastases [J].
Min Shi ;
Zhongyin Yang ;
Sheng Lu ;
Wentao Liu ;
Zhentian Ni ;
Xuexin Yao ;
Zichen Hua ;
Runhua Feng ;
Yanan Zheng ;
Zhenqiang Wang ;
Birendra Kumar Sah ;
Mingmin Chen ;
Zhenglun Zhu ;
Changyu He ;
Chen Li ;
Jun Zhang ;
Chao Yan ;
Min Yan ;
Zhenggang Zhu .
BMC Cancer, 21
[17]   Intraperitoneal infusion of paclitaxel with S-1 for peritoneal metastasis of advanced gastric cancer : phase I study [J].
Kurita, Nobuhiro ;
Shimada, Mitsuo ;
Iwata, Takashi ;
Nishioka, Masanori ;
Morimoto, Shinya ;
Yoshikawa, Kozo ;
Higashijima, Jun ;
Miyatani, Tomohiko ;
Nakao, Toshihiro .
JOURNAL OF MEDICAL INVESTIGATION, 2011, 58 (1-2) :134-139
[18]   Salvage Gastrectomy After Intravenous and Intraperitoneal Paclitaxel (PTX) Administration with Oral S-1 for Peritoneal Dissemination of Advanced Gastric Cancer with Malignant Ascites [J].
Joji Kitayama ;
Hironori Ishigami ;
Hironori Yamaguchi ;
Hiroharu Yamashita ;
Shigenobu Emoto ;
Shoich Kaisaki ;
Toshiaki Watanabe .
Annals of Surgical Oncology, 2014, 21 :539-546
[19]   Phase II trial of neoadjuvant chemotherapy with intraperitoneal paclitaxel, S-1, and intravenous cisplatin and paclitaxel for stage IIIA or IIIB gastric cancer [J].
Shinkai, Masayuki ;
Imano, Motohiro ;
Chiba, Yasutaka ;
Iwama, Mitsuru ;
Shiraisi, Osamu ;
Yasuda, Atsushi ;
Tsubaki, Masanobu ;
Nishida, Shozo ;
Kimura, Yutaka ;
Yasuda, Takushi .
JOURNAL OF SURGICAL ONCOLOGY, 2019, 119 (01) :56-63
[20]   Treatment strategy of intraperitoneal and systemic chemotherapy combined with gastrectomy for gastric cancer with peritoneal metastasis [J].
Kobayashi, Daisuke ;
Kanda, Mitsuro ;
Tanaka, Chie ;
Sonohara, Fuminori ;
Suenaga, Masaya ;
Takami, Hideki ;
Hattori, Norifumi ;
Niwa, Yukiko ;
Hayashi, Masamichi ;
Yamada, Suguru ;
Nakayama, Goro ;
Koike, Masahiko ;
Fujiwara, Michitaka ;
Kodera, Yasuhiro .
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2018, 33 :98-98